Advice You - Business

Most MBA classes concentrate on change management at the Corporat

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

e Board Room and CEO levels and yet for every corporate board of

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

directors there might be hundreds or even thousands of outlets an

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

d subdivisions. Change Management cycles are equally as important

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

to same store sales, company profits and efficiencies at the uni

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

t level.

If the team members and management at the store outlet

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

level do not work together then the store is not efficient, sales

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

slack and the system crumbles. If on the other hand at the store

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

level everything is running smoothly at all stores then the Corp

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

orate Board Members look like geniuses, take all the credit, reti

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

e on the Golf Course and write a management book.

Indeed the cor

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

porate level folks are partly to thank or to blame for the manage

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ment at the unit or store level and yet without proper training a

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

nd team work at that level nothing good will happen and the custo

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

mers will know it and sales will drop off too.

Goals and conditi

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ons along with mission statements must be set and agreed upon by

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

verbal, written and social contract between managers, assistant m

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

anagers, swing-shift managers and team leaders of each department

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

at each store or outlet. If not the system breaks down and every

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

one loses, especially the shareholders. Consider all this in 2006

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/14057/adviceyou-Change-Management-at-the-Unit-Outlet-Management-Level.html">Change Management at the Unit Outlet Management Level</a>

BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/14057/adviceyou-Change-Management-at-the-Unit-Outlet-Management-Level.html]Change Management at the Unit Outlet Management Level[/url]

While installing your new accounting software you have most likely been asked whether you would like to use one of the default charts of accounts included with the program or develop your own. But you may ask what if I don’t need all these accounts and how do I know which accounts I should keep. And should I use a numbering system or not? Let me help.

Those who want to become a private investigator should do more than just getting the right training. This is because many states require the individual to get a license first to be able to practice this profession.

Organisations looking to implement improvement often fail to achieve the results they are looking for - yet when you analyse the reasons why their improvement programmes (Lean, Six Sigma etc) fail, it can normally be traced back to one of nine reasons - and this article tells you how!

Tags

Links

Advice You - Change Management at the Unit Outlet Management Level

Related Articles: